share_log

Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144

Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144

Teladoc Health | 144：拟议出售证券
美股sec公告 ·  05/02 15:30
Moomoo AI 已提取核心信息
Teladoc Health, Inc. officer Laizer Kornwasser is set to sell 10,411 shares of common stock on 05/02/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $132,095.81, were acquired on 05/01/2024 through restricted stock vesting as part of compensation from the issuer. This transaction follows a recent history of sales by Kornwasser over the past three months, totaling 26,231 shares for gross proceeds of $417,508.52.
Teladoc Health, Inc. officer Laizer Kornwasser is set to sell 10,411 shares of common stock on 05/02/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $132,095.81, were acquired on 05/01/2024 through restricted stock vesting as part of compensation from the issuer. This transaction follows a recent history of sales by Kornwasser over the past three months, totaling 26,231 shares for gross proceeds of $417,508.52.
正如在最近的一份文件中宣布的那样，Teladoc Health, Inc.高管莱泽·科恩瓦瑟定于2024年2月5日出售10,411股普通股。这些股票的总市值为132,095.81美元，作为发行人补偿的一部分，于2024年1月5日通过限制性股票归属收购。该交易遵循了Kornwasser在过去三个月中的近期销售记录，共计26,231股股票，总收益为417,508.52美元。
正如在最近的一份文件中宣布的那样，Teladoc Health, Inc.高管莱泽·科恩瓦瑟定于2024年2月5日出售10,411股普通股。这些股票的总市值为132,095.81美元，作为发行人补偿的一部分，于2024年1月5日通过限制性股票归属收购。该交易遵循了Kornwasser在过去三个月中的近期销售记录，共计26,231股股票，总收益为417,508.52美元。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息